2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole,
4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzimidazole,
DMAT cpd,
DMAT,
749234-11-5,
CK2 Inhibitor II,
4,5,6,7-TETRABROMO-N,N-DIMETHYL-1H-BENZIMIDAZOL-2-AMINE,
ck2inhibitor,
4,5,6,7-tetrabroMo-N,N-diMethyl-1H-benzo[d]iMidazol-2-aMine,
2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole,
CK2 Inhibitor II, DMAT,
CHEMBL376505,
DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE,
Casein Kinase II Inhibitor II, DMAT,
InSolution™ Casein Kinase II Inhibitor, DMAT,
1zoe,
K25,
CK2 Inhibitor 2,
DMAT(CK2 Inhibitor),
C9H7br4N3,
AC1NS1F7,
SCHEMBL263870,
GTPL9323,
CTK2G1233,
DTXSID70416119,
SLPJGDQJLTYWCI-UHFFFAOYSA-N,
DMAT, >=98% (HPLC),
ZINC8830553,
3265AH,
BDBM50156670,
MFCD08705322,
AKOS005137997,
CS-1289,
DB04719,
KIN0000094,
LP00351,
KS-0000006Q,
SMP2_000032,
NCGC00093787-01,
NCGC00093787-02,
NCGC00093787-03,
HY-15535,
W-5381,
2-Dimethylamino-4,5,6,7-tetrabromobenzimidazole,
2-(dimethylamino)-4,5,6,7-tetrabromo-1H-benzimidazole,
1H-Benzimidazol-2-amine, 4,5,6,7-tetrabromo-N,N-dimethyl-,
(4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzo[d]imidazol-2-amine),
DMAT cpd,
CID5326976,
A3368,
A15069,
C492322,
4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzimidazole,